What Can You Expect at the Measuring Impact in Medical Affairs Summit
The Measuring Impact in Medical Affairs Summit is your opportunity to explore how Medical Affairs is evolving into a truly strategic, impact-driven function. This unique meeting brings together leaders from pharma and biotech to share practical approaches for designing meaningful KPIs, leveraging AI and digital tools, and demonstrating the real-world value of Medical Affairs activities.
Expect interactive workshops, expert-led sessions, and case studies that show how top teams capture high-quality insights, communicate impact to leadership, and align cross-functional initiatives to drive measurable outcomes. From Field Medical to Medical Communications Evidence Generation and more, discover how every subfunction can contribute to a unified strategy for success.
Join 60+ senior Medical Affairs professionals from organizations including Regeneron, Boehringer Ingelheim, Abbvie, Alexion, and Travere to connect, share best practices, and gain actionable insights you can take back to your team. Leave equipped to transform data, insights, and relationships into demonstrable impact and to play a leading role in defining the next generation of Medical Affairs excellence.
Unmissable Event Highlights
Translating Insights into Impact, Boehringer’s approach to building Practical KPI framework Across Medical Subfunctions
Boehringer Ingelheim’s Bill Tidwell and Greg Gillum share how to create fit-for-purpose KPIs that capture the unique value of Field Medical, Communications, and Evidence Generation teams, and align metrics with organizational goals to clearly demonstrate impact.
Redefining How Medical Affairs Measures Success Beyond Quantitative Measures
Sanofi’s Robert Johnson explores how to move beyond activity counts to metrics that truly reflect influence, linking Medical Affairs initiatives to clinical decisions, patient outcomes, and stronger HCP relationships.
Bridging the Gap and Turning Scientific Insights into Strategic Action
AbbVie’s Denise Briggs reveals how Medical Affairs teams can systematically capture and share insights across R&D and commercial functions — proving their strategic value through aligned objectives and measurable outcomes.
Attending Companies Include